Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus

Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids

(2013) Marie B Condon et al.   ANNALS OF THE RHEUMATIC DISEASES

Prednisone in lupus nephritis: How much is enough?

(2013) Guillermo Ruiz-Irastorza et al.   AUTOIMMUNITY REVIEWS

Predictors of organ damage in systemic lupus erythematosus: The Hopkins Lupus Cohort

(2012) Michelle Petri et al.   ARTHRITIS AND RHEUMATISM

Renal Outcome in Patients with Lupus Nephritis Using a Steroid-free Regimen of Monthly Intravenous Cyclophosphamide: A Prospective Observational Study

(2012) R. FISCHER-BETZ et al.   JOURNAL OF RHEUMATOLOGY

The Humanistic and Economic Burden of Systemic Lupus Erythematosus

(2012) Rachel Meacock et al.   PHARMACOECONOMICS

Glucocorticoid use and abuse in SLE

(2012) G. Ruiz-Irastorza et al.   RHEUMATOLOGY

Unmet medical needs in systemic lupus erythematosus

(2012) Aisha Lateef et al.   ARTHRITIS RESEARCH & THERAPY

Prednisone, Lupus Activity, and Permanent Organ Damage

(2009) M. THAMER et al.   JOURNAL OF RHEUMATOLOGY

Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years

(2009) S. A. Chambers et al.   RHEUMATOLOGY